dihydrotachysterol and Asphyxia-Neonatorum

dihydrotachysterol has been researched along with Asphyxia-Neonatorum* in 1 studies

Other Studies

1 other study(ies) available for dihydrotachysterol and Asphyxia-Neonatorum

ArticleYear
Outcome of infants with 10 min Apgar scores of 0-1 in a low-resource setting.
    Archives of disease in childhood. Fetal and neonatal edition, 2022, Volume: 107, Issue:4

    In high-resource settings, postponing the interruption of cardiopulmonary resuscitation from 10 to 20 min after birth has been recently suggested, but data from low-resource settings are lacking. We investigated the outcome of newborns with Apgar scores of 0-1 at 10 min of resuscitative efforts in a low-resource setting.. This observational substudy from the NeoSupra trial included all 49 late preterm/full-term newborns with Apgar scores of 0-1 at 10 min of resuscitation. The study was carried out at Mulago National Referral Hospital (Kampala, Uganda) between May 2018 and August 2019. Outcome measures were mortality and hypoxic-ischaemic encephalopathy in the first week of life. All resuscitations were video recorded and daily reviewed by trial researchers.. Median duration of resuscitation was 32 min (IQR 17-37). Advanced resuscitation was provided to 21/49 neonates (43%). Overall, 48 neonates (98%) died within 2 days of life (44 in the delivery room, three on the first day and one on the second day) and one survived at 1 week with severe hypoxic-ischaemic encephalopathy.. Our study adds information from a low-resource setting to the recent evidence from high-resource settings about prolonging the resuscitation in infants with Apgar scores of 0-1 at 10 min. The vast majority died in the delivery room despite prolonged resuscitative efforts. We confirm that duration of resuscitation should be tailored to the setting, while the focus in low-resource settings should be improving the quality of antenatal and immediately after birth care.

    Topics: Apgar Score; Asphyxia Neonatorum; Cardiopulmonary Resuscitation; Dihydrotachysterol; Female; Humans; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn; Pregnancy; Resuscitation; Uganda

2022